Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Dial Corp.

This article was originally published in The Rose Sheet

Executive Summary

Consumer products division revenues rose 13% in the first quarter, and operating income gained 18%. The company's consumer products include Dial liquid and bar soap and deodorant and Breck hair care. Consolidated revenues increased 23% to $784.9 mil. Net income was $17.2 mil., up 17.6%. Separately, Dial announced a 2- for-1 stock split, which will be effected as a tax-free stock dividend to be paid July 1, to shareholders of record by June 1. The stock split is intended to "send a positive signal about future stock price performance, achieve more attractive stock price levels to appeal to more types of investors, increase [the] stockholder base and increase float and liquidity in Dial common stock," the firm said

Latest Headlines
See All
UsernamePublicRestriction

Register

RS000444

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel